BSP Pharmaceuticals S.p.A. was pleased to announce its presence to the next 6th World ADC Summit 2015 in San Diego. The annual summit - was the main scientific event for the research, development and production of anticancer drugs ADC (Antibody Drug Conjugation). During the first day of this Summit, at 13.30 PM, Maria Elena Guadagno, our Business Director held the speech: “Conjugation & Fill-Finish at the Same Site, an Innovative Approach to the Supply of ADCs”. This summit covers every aspect of ADC development, from target validation through to commercial scale manufacturing. The ADC World Summit was engaged to divulge the latest science and data powering the ADC drug pipelines to clinical therapeutic success.
